Bioactivity:

CP-320626 is an effective inhibitor of glycogen phosphorylase A (LGPA) in the human liver and GPA in the human muscle. Can act synergistically with glucose. It is a possible target for the treatment of type 2 diabetes.

CAS nr:

186430-23-9

Purity:

98%

Molecular Weight:

443,9

SMILES:

O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=C(F)C=C3)C(N4CCC(O)CC4)=O

Formula:

C23H23ClFN3O3

Pathway:

Target: